A case alleging that the maker of Enfamil infant formula is liable for causing an infant’s brain damage will proceed in district court after the U.S. Supreme Court on Monday denied the company’s petition for writ of certiorari.
Mead Johnson & Co. had asked the high court to hear the case in the wake of a decision by the U.S. Court of Appeals for the Eighth Circuit, which concluded in June that a judge improperly excluded the opinion of three experts that Enfamil may have caused the baby’s injury.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
